Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials .PARAMOUNT:Final overall survival(OS)results of the phase Ⅲ study of maintenance pemetrexed(pem)plus be ......